SME · BSE SMEListed
ACCRETION NUTRAVEDA LIMITED IPO: dates, price band, lot size, objects of the issue
Get analyst updates on this IPO
Analyst updates come by email.What changed since listing, from SEBI-registered research analysts.
By continuing you agree to the Terms and Privacy policy
Key facts
- Issue size at the upper band
- ₹24.77 crore
- Listing date
- Wed 4 Feb 2026
- BSE daily price file for Wed 4 Feb 2026
Timeline (IST)
- OpensWed 28 Jan 2026, 10:00 am IST confirmedProspectus dated Mon 2 Feb 2026, page 1
- ClosesFri 30 Jan 2026 confirmedProspectus dated Mon 2 Feb 2026, page 1
- UPI mandate cut-offNot stated in the prospectus Prospectus dated Mon 2 Feb 2026
- AllotmentMon 2 Feb 2026 by T+3 schedule
- Refund and unblockTue 3 Feb 2026 by T+3 schedule
- Shares to dematTue 3 Feb 2026 by T+3 schedule
- ListingWed 4 Feb 2026 confirmedBSE daily price file for Wed 4 Feb 2026
Objects of the issue
| Object | Amount |
|---|---|
| Purchase of Machineries for Automation in existing Manufacturing unit | ₹4.22 crore |
| Purchase of Machineries for New Manufacturing Setup | ₹8.03 crore |
| Funding working capital requirements of our company | ₹5.50 crore |
| General corporate purposes | ₹3.69 crore |
| Total | ₹21.44 crore |
Prospectus dated Mon 2 Feb 2026, page 136
Company and promoters
As described in the prospectus
Accretion Nutraveda Limited, founded in 2021 in Ahmedabad, is a healthcare-focused Contract Development and Manufacturing Organization (CDMO).
Prospectus dated Mon 2 Feb 2026, page 30
Promoters
- 6 individual promoters
Prospectus dated Mon 2 Feb 2026, page 30
Shareholding
| Holding | Before the issue | After the issue |
|---|---|---|
| Promoters and promoter group | 100.00% | 73.48% |
Basis: At the upper end of the price band
Prospectus dated Mon 2 Feb 2026, pages 31 to 126
Financials (restated)
| Item | September 30, 2025 | March 31, 2025 | March 31, 2024 | March 31, 2023 |
|---|---|---|---|---|
| Revenue from operations | ₹14.06 crore | ₹16.00 crore | ₹5.01 crore | ₹2.90 crore |
| Profit after tax | ₹2.33 crore | ₹2.61 crore | ₹82.19 lakh | ₹28.06 lakh |
| Net worth | ₹8.27 crore | ₹5.35 crore | ₹1.08 crore | ₹26.31 lakh |
| Total borrowings | Not stated in the prospectus | Not stated in the prospectus | Not stated in the prospectus | Not stated in the prospectus |
Prospectus dated Mon 2 Feb 2026, page 80
SME issue facts
- The face value of each Equity Share is ₹10/- and the Floor Price is ₹122/- per Equity Share and the Cap Price is ₹129/- (Prospectus dated Mon 2 Feb 2026, page 402)
- that the minimum application size shall be two lots per application. Provided that the minimum application size shall be (Prospectus dated Mon 2 Feb 2026, page 404)
- happen in the minimum contract size of 1000 Equity Shares and the same may be modified by the BSE SME from time (Prospectus dated Mon 2 Feb 2026, page 404)
- done in multiples of 1000 Equity Shares and is subject to a minimum allotment of 2000 Equity Shares to the successful (Prospectus dated Mon 2 Feb 2026, page 404)
- this Issue shall be 200 shareholders. In case the minimum number of prospective allottees is less than 200, no allotment (Prospectus dated Mon 2 Feb 2026, page 404)
Peer comparison (as in the Prospectus)
| Name of the company | Current market price (₹) | Face value (₹) | EPS (Basic & Diluted) | PE | RONW (%) | NAV Per share (₹) | Total income (₹ In lakhs) |
|---|---|---|---|---|---|---|---|
| Accretion Nutraveda Limited | 129/- | 10 | 4.73 | 27.27 | 56.50% | 16.74 | 1406.55 |
| Walpar Nutritions Ltd. | 45.90 | 10 | 1.06 | 3.30 | 6.24% | 17.05 | 2879.72 |
| Influx Healthtech Limited | 226.00 | 10 | 4.81 | 46.99 | 11.10% | 38.98 | 6685.92 |
Reproduced from the Prospectus dated Mon 2 Feb 2026, pages 160 to 161; InsightPier adds no figures
Risk factors
83 total- Equipment failure, accidents or natural disasters at the single manufacturing facility could disrupt production (offer document page 39)
- Discrepancies and delayed filings in statutory forms with the Registrar of Companies could lead to penalties (offer document page 39)
- A few customers account for most sales, so losing one could hurt revenue (offer document page 41)
- Most revenue comes from Gujarat, concentrating geographic risk (offer document page 42)
- Orders for the machinery funded by the issue are not yet placed, so delays or cost increases are possible (offer document page 43)
All 83 risk factors, pages 38 to 74
Offer document
Allotment and bids
Registrar to the issue: KFin Technologies Limited.
Allotment status was expected on the registrar's site from Mon 2 Feb 2026 and is not yet confirmed. Pick "ACCRETION NUTRAVEDA LIMITED" from the issue list there.
Subscription (final)
| Category | Shares offered | Shares bid for | Times subscribed |
|---|---|---|---|
| Overall | – | – | 1.91× |
ipocentral.in and ipowatch.in, as of Tue 17 Nov 2026